Literature DB >> 9635212

Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder.

J Swanson1, F X Castellanos, M Murias, G LaHoste, J Kennedy.   

Abstract

Currently, diagnoses of attention deficit hyperactivity disorder (ADHD) and hyperkinetic disorder (HKD) are made on the basis of phenomenology, but information is accumulating from the neurosciences about the biological bases of these disorders. Recent studies addressing the neuropsychology, neuroanatomy, neurochemistry, and molecular biology of ADHD/HKD document abnormalities in well-defined neuroanatomical networks and neurochemical pathways. Magnetic resonance imaging (MRI) studies have shown that some regions of the frontal lobes (anterior superior and inferior) and basal ganglia (caudate nucleus and globus pallidus) are about 10% smaller in ADHD groups than in control groups of children, and molecular genetic studies have shown that diagnosis of ADHD is associated with polymorphisms in some dopamine genes (the dopamine D4 receptor gene and the dopamine transporter gene).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635212     DOI: 10.1016/s0959-4388(98)80150-5

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  38 in total

Review 1.  Hyperactivity in children: a focus on genetic research and psychological theories.

Authors:  J Kuntsi; J Stevenson
Journal:  Clin Child Fam Psychol Rev       Date:  2000-03

Review 2.  Genes and attention deficit hyperactivity disorder.

Authors:  J Swanson; M Posner; J Fusella; M Wasdell; T Sommer; J Fan
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

3.  Dopamine D4 receptor-deficient mice display cortical hyperexcitability.

Authors:  M Rubinstein; C Cepeda; R S Hurst; J Flores-Hernandez; M A Ariano; T L Falzone; L B Kozell; C K Meshul; J R Bunzow; M J Low; M S Levine; D K Grandy
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

4.  Gestational age, birth weight, and the risk of hyperkinetic disorder.

Authors:  K M Linnet; K Wisborg; E Agerbo; N J Secher; P H Thomsen; T B Henriksen
Journal:  Arch Dis Child       Date:  2006-06-05       Impact factor: 3.791

5.  Scent marking behavior in male C57BL/6J mice: sexual and developmental determination.

Authors:  Hiroyuki Arakawa; Keiko Arakawa; D Caroline Blanchard; Robert J Blanchard
Journal:  Behav Brain Res       Date:  2007-05-22       Impact factor: 3.332

6.  Chronic Treatment with a Clinically Relevant Dose of Methylphenidate Increases Glutamate Levels in Cerebrospinal Fluid and Impairs Glutamatergic Homeostasis in Prefrontal Cortex of Juvenile Rats.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Daniella M Coelho; Ben Hur Mussulini; Mery S L Pereira; Mariana M Parisi; Florencia Barbé-Tuana; Diogo L de Oliveira; Carmen R Vargas; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2015-05-24       Impact factor: 5.590

7.  Frequency and function in the basal ganglia: the origins of beta and gamma band activity.

Authors:  Alexander Blenkinsop; Sean Anderson; Kevin Gurney
Journal:  J Physiol       Date:  2017-06-05       Impact factor: 5.182

8.  Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.

Authors:  Danielle C Turner; Andrew D Blackwell; Jonathan H Dowson; Andrew McLean; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Ontogenetic expression of dopamine-related transcription factors and tyrosine hydroxylase in prenatally stressed rats.

Authors:  Maria R Katunar; Trinidad Saez; Alicia Brusco; Marta C Antonelli
Journal:  Neurotox Res       Date:  2009-11-20       Impact factor: 3.911

10.  A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Thomas Rugino
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.